NYSE:DNA | Profit Breakdown | Ginkgo Bioworks Holdings, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$20.16M-$58.55M-$57.19M-$46.71M
2026-03-31$19.47M-$71.37M-$76.14M-$82.59M
2025-12-31$33.4M-$70.75M-$81.39M-$80.75M
2025-09-30$38.84M-$90.02M-$80.75M-$80.76M
2025-06-30$39.13M-$58.16M-$53.48M-$60.3M
2025-03-31$38.23M-$80.97M-$83.22M-$90.96M
2024-12-31$43.85M-$103.61M-$107.86M-$107.53M
2024-09-30$89.05M-$55.2M-$56.78M-$56.4M
2024-06-30$56.21M-$222.95M-$216.99M-$217.18M
2024-03-31$37.94M-$178M-$165.88M-$165.91M
2023-12-31$34.76M-$178.12M-$211.89M-$211.69M
2023-09-30$55.43M-$286.39M-$302.91M-$302.89M
2023-06-30$80.57M-$184.15M-$173.25M-$173.32M
2023-03-31$80.7M-$215.75M-$204.89M-$204.97M
2022-12-31$98.29M-$230.86M-$187.85M-$175.47M
2022-09-30$66.4M-$654.94M-$670.16M-$670.13M
2022-06-30$144.62M-$647.78M-$670.62M-$668.83M
2022-03-31$168.41M-$675.37M-$592.78M-$590.51M
2021-12-31$148.49M-$1.68B-$1.61B-$1.6B
2021-09-30$77.61M-$26.67M-$102.61M-$101.88M
2021-06-30$43.64M-$59.95M-$54.9M-$53.94M
2021-03-31$44.1M-$57.12M-$74.94M-$73.57M
2020-12-31$32.06M-$55.89M-$46.39M-$46.92M
2020-09-30$13.3M-$34.41M-$26.12M-$26.06M
2020-06-30-$28.73M
2020-03-31-$25.47M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$170.16M-$315.28M-$313.6M-$312.76M
2024-12-31$227.04M-$559.76M-$547.51M-$547.03M
2023-12-31$251.46M-$864.41M-$892.94M-$892.87M
2022-12-31$477.71M-$2.21B-$2.12B-$2.1B
2021-12-31$313.84M-$1.83B-$1.84B-$1.83B
2020-12-31$76.66M-$137.03M-$124.83M-$126.61M
2019-12-31$54.18M-$71.6M-$119.84M-$119.33M